Best SSRI for Anxiety

Primary Recommendation

The American Academy of Child and Adolescent Psychiatry recommends sertraline as the first-line SSRI for treating anxiety disorders, including social anxiety disorder, generalized anxiety disorder, panic disorder, and PTSD, based on substantial empirical evidence supporting its effectiveness and safety across multiple anxiety disorder subtypes 1
Sertraline is the recommended first-line SSRI for anxiety disorders based on the strongest evidence for efficacy, safety, favorable tolerability profile, and minimal drug interactions 1, 2

The American College of Psychiatry recommends escitalopram as a first-line alternative with potentially fewer drug interactions than other SSRIs 3
Escitalopram is considered as a second choice if sertraline is not tolerated or ineffective 3
Paroxetine is effective for anxiety disorders but carries a higher risk of discontinuation syndrome 3
Fluvoxamine is effective but also associated with a higher discontinuation syndrome risk 3

Start with a subtherapeutic "test" dose to minimize initial anxiety or agitation that can occur with SSRI initiation 1, 2
Increase dose at 1-2 week intervals in small increments for mild to moderate anxiety 1
Titrate until optimal benefit-to-harm ratio is achieved 1

Combining sertraline with cognitive behavioral therapy (CBT) provides superior outcomes compared to either treatment alone 1, 2, 3
CBT structure consists of approximately 14 individual sessions over 4 months, with each session lasting 60-90 minutes 3

Common side effects include gastrointestinal symptoms, headache, somnolence, insomnia, dizziness, and appetite changes 1, 3
Serious adverse effects include serotonin syndrome risk, particularly when combined with other serotonergic medications, MAOIs, linezolid, or methylene blue 1, 3
Monitor for suicidal thinking, especially in the first months of treatment and following dosage adjustments 2

Sertraline has a shorter half-life requiring gradual tapering to minimize discontinuation symptoms 2, 3
Discontinuation symptoms include dizziness, fatigue, headaches, nausea, insomnia, and anxiety 3
Relapse is more common after medication discontinuation compared to after CBT completion 2

Systematically assess treatment response using standardized symptom rating scales 3
Re-evaluate at 6 weeks for clinically significant improvement 1
If inadequate response by 12 weeks, consider dose optimization before switching medications 1, 3

In Japan, fluvoxamine, paroxetine, and escitalopram are suggested as first choice for social anxiety disorder, but sertraline has been reported to be as effective and well-tolerated as these approved drugs 4